Last reviewed · How we verify

NCT07283510: AAIMLCOA

Community-based Functional Fitness for Adults Aging With Mobility Disability

Completed NA Last updated 22 December 2025
What this trial tests

NA trial testing Functional Fitness in Mobility Disability in 13 participants. Completed in 1 December 2024.

Timeline
17 October 2023
Primary endpoint
20 November 2024
1 December 2024

Quick facts

Lead sponsorUniversity of Kansas
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment13
Start date17 October 2023
Primary completion20 November 2024
Estimated completion1 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Kansas

Who can join

60 and older, any sex, with Mobility Disability or Older Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the feasibility and potential effectiveness of a 12-week, high-intensity functional training (HIFT) intervention on frailty in older adults (60+) with mobility disabilities (MD) who are ambulatory

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. High-Intensity Functional Training for Older Adults with Mobility Disabilities: A Feasibility Pilot Study.
    Koon LM, Donnelly JE, Sosnoff JJ, Tabatabaei A, et al · · 2026 · PMID 41682198 · DOI 10.3390/healthcare14030349

Verify or expand the search:

Other trials of Functional Fitness

Trials testing the same drug.

Other recruiting trials for Mobility Disability

Currently open trials in the same condition.

Other University of Kansas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07283510.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing